Please login to the form below

Not currently logged in
Email:
Password:

Anish Mehta appointed CEO of new women's health business

Will head up the former Teva portoflio CVC Capital Partners recently acquired

Anish MehtaLondon-based investment firm CVC Capital Partners has appointed Anish Mehta as chief executive officer of the international women’s health assets portfolio it acquired from Teva Pharmaceuticals last month.

Mehta joins from Allergan, where he was head of international business development leading the team responsible for corporate development and licensing activity in support of the international business.

He said: “I am honoured to have this opportunity to partner with CVC and the existing team to lead this exciting new business.

The combination of high quality products and a talented team creates a unique opportunity for us to build a leading, global, speciality pharmaceutical business dedicated to women’s health.”

Prior to his new role, Mehta has served at Actavis, taking the helm of its European and Middle East business, where he managed a portfolio of pharmaceutical products.

Cathrin Petty, partner and head of European Healthcare, CVC, said: “Anish is a well-established industry veteran, having spent over 20 years in the global healthcare space.

“His deep experience in M&A, complex carve outs and building businesses will be invaluable to us as we look to scale this business.”

19th October 2017

From: Sales

Share

Tags

Subscribe to our email news alerts

Featured jobs

PMHub

Add my company
Onyx Health

Onyx Health is a healthcare communications and PR agency based in the North East of England, but with a national...

Latest intelligence

Top-10 Reasons Why You Should be Adding Asynchronous Virtual Touchpoints Between Your Real-time Meetings
...
Flu
Influenza – the risk to vulnerable populations
Why we can't get complacent about flu vaccination...
dementia
Alzheimer’s Research UK highlights socio-economic inequalities in dementia risk
The charity aims to improve the number of women participating in dementia research and grow awareness of dementia risk factors...